Phibro Animal Health (PAHC) Downgraded to Strong Sell at BidaskClub

BidaskClub lowered shares of Phibro Animal Health (NASDAQ:PAHC) from a sell rating to a strong sell rating in a report published on Wednesday morning.

PAHC has been the subject of several other research reports. Zacks Investment Research cut Phibro Animal Health from a hold rating to a strong sell rating in a report on Wednesday, October 24th. Morgan Stanley upped their price target on Phibro Animal Health from $36.00 to $46.00 and gave the company an underweight rating in a report on Wednesday, August 29th. Finally, ValuEngine cut Phibro Animal Health from a buy rating to a hold rating in a report on Monday, November 12th. Three investment analysts have rated the stock with a sell rating and three have given a hold rating to the company’s stock. The stock currently has an average rating of Hold and a consensus target price of $43.50.

Phibro Animal Health stock opened at $33.90 on Wednesday. The company has a quick ratio of 1.82, a current ratio of 3.26 and a debt-to-equity ratio of 1.62. The company has a market capitalization of $1.37 billion, a price-to-earnings ratio of 19.37, a PEG ratio of 2.90 and a beta of 0.82. Phibro Animal Health has a 12 month low of $32.05 and a 12 month high of $54.62.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings results on Tuesday, November 6th. The company reported $0.39 EPS for the quarter, missing the consensus estimate of $0.42 by ($0.03). The firm had revenue of $200.20 million during the quarter, compared to analyst estimates of $203.99 million. Phibro Animal Health had a net margin of 7.89% and a return on equity of 38.91%. The company’s revenue was up 3.5% on a year-over-year basis. During the same period last year, the company earned $0.38 EPS. As a group, analysts expect that Phibro Animal Health will post 1.72 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 19th. Shareholders of record on Wednesday, November 28th will be issued a $0.12 dividend. This is a boost from Phibro Animal Health’s previous quarterly dividend of $0.10. The ex-dividend date of this dividend is Tuesday, November 27th. This represents a $0.48 annualized dividend and a yield of 1.42%. Phibro Animal Health’s dividend payout ratio is 27.59%.

In other news, insider Jack Bendheim sold 20,000 shares of the stock in a transaction that occurred on Thursday, September 6th. The stock was sold at an average price of $47.14, for a total value of $942,800.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Dean J. Warras sold 10,000 shares of the stock in a transaction that occurred on Thursday, November 1st. The stock was sold at an average price of $42.84, for a total value of $428,400.00. Following the completion of the transaction, the insider now directly owns 10,000 shares of the company’s stock, valued at $428,400. The disclosure for this sale can be found here. Over the last three months, insiders sold 43,020 shares of company stock valued at $1,978,371. 50.29% of the stock is currently owned by insiders.

Several institutional investors and hedge funds have recently modified their holdings of the company. Vanguard Group Inc. raised its holdings in shares of Phibro Animal Health by 3.3% in the 3rd quarter. Vanguard Group Inc. now owns 2,074,840 shares of the company’s stock worth $89,011,000 after buying an additional 66,676 shares in the last quarter. Morgan Stanley raised its holdings in shares of Phibro Animal Health by 89.8% in the 3rd quarter. Morgan Stanley now owns 362,872 shares of the company’s stock worth $15,567,000 after buying an additional 171,639 shares in the last quarter. Legal & General Group Plc raised its holdings in shares of Phibro Animal Health by 10.7% in the 3rd quarter. Legal & General Group Plc now owns 43,295 shares of the company’s stock worth $1,852,000 after buying an additional 4,188 shares in the last quarter. TIAA CREF Investment Management LLC raised its holdings in shares of Phibro Animal Health by 10.1% in the 3rd quarter. TIAA CREF Investment Management LLC now owns 224,815 shares of the company’s stock worth $9,645,000 after buying an additional 20,562 shares in the last quarter. Finally, MetLife Investment Advisors LLC raised its holdings in shares of Phibro Animal Health by 51.1% in the 3rd quarter. MetLife Investment Advisors LLC now owns 15,103 shares of the company’s stock worth $648,000 after buying an additional 5,110 shares in the last quarter. 48.33% of the stock is owned by institutional investors and hedge funds.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Further Reading: How to Use a Moving Average for Trading 

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit